AmSurg boss in line for bigger bonus
Mar 2, 2011 7:31 AM
BlackRock adds to AmSurg, America Service stakes
Feb 4, 2011 10:25 AM
Investors see brighter 2011 for AmSurg
Shares of AmSurg ended Tuesday 2 percent higher on more than double their typical trading volume as investors look forward to an economic recovery that should help boost patient volumes for the Nashville surgery center chain in early 2011. AmSurg struggled with volumes all year as cash-strapped patients put off elective procedures. But starting in January, the new health reform law eliminates co-pays for colonoscopies — which represent about 25 percent of the company's GI business. Add to that a rise in consumer confidence, and AmSurg could reap the benefits of pent up patient demand with upticks in volume in the first and second quarters, according to the local office of Jefferies & Co. AmSurg (Ticker: AMSG) closed at $20.80 per share Tuesday. Year-to-date shares are down about 5.5 percent. Dec 15, 2010 7:31 AM
Market has AmSurg all wrong
The folks at markets website Vuru say investors were overreacting when they fled AmSurg after the passage of health reform because they feared Medicare spending cuts. Yes, the surgery center chain has government exposure, they say, but it will not be a meaningful long-term factor.The key takeaway is that there is a tangible risk in AMSG's reliance on Medicare. But if you're comfortable with that, the government tightening its belt is merely an issue to keep on your radar for the future.Shares of AmSurg (Ticker: AMSG) are down about 8 percent year to date.
Dec 13, 2010 9:09 AM
AmSurg execs sell shares
A trio of senior figures at surgery center chain AmSurg last week joined the insider-selling bandwagon. CFO Claire Gulmi and Chief Development Officer David Manning both exercised batches of options and then sold the shares for profits of $61,000 and $85,000, respectively. Director Steven Geringer, for his part, sold 2,000 of his shares. AmSurg (Ticker: AMSG) are down about 15 percent this year. Nov 17, 2010 9:41 AM
Analyst action: Dollar General, AmSurg
Saying that "changes in guidance are not alarming to us, and are mainly due to changes in timing of acquisitions rather than a shift in market dynamics," Avondale Partners analyst Brian Williams on Friday reiterated his 'market perform' rating and $20 price target on shares of AmSurg. He also tweaked downward his earnings estimates in the surgery center chain (Ticker: AMSG) and said any real upturn can only come with a better economy that doesn't force people to put off procedures. Barclays analysts have hiked their EPS forecast for Dollar General (Ticker: DG) based on their view of the discount retailer's operations. They see Goodlettsville-based Dollar General growing earnings by 24 percent in 2011, which puts them 6 percent above the Street's consensus. Oct 25, 2010 7:42 AM
Look for better AmSurg volumes
Avondale Partners analyst Brian Williams says patient traffic at surgery center chain AmSurg is slowly mending, but investors will likely have to wait another quarter to see decent growth.While 3Q volumes appear to be returning to a flat run rate, management is still uncertain when growth will return to historical levels. Some procedures may also be delayed to 4Q10 as individuals meet deductible levels.Williams, who has a 'market perform' rating on AmSurg, expects the company (Ticker: AMSG) to report this afternoon a Q3 profit of 43 cents per diluted share, a penny more than the consensus.
Oct 21, 2010 11:44 AM
|
AmSurg board member resigns
Debora Guthrie has resigned from AmSurg Corp.’s board of directors. The ambulatory surgery center company announced Guthrie’s resignation in a regulatory filing yesterday. Following her departure from the board, an affiliate of Guthrie's company, Capitol Health, will serve as a consultant to AmSurg. Oct 1, 2010 7:01 AM
|
Analyst action: CHS, AmSurg
Barclays Capital analyst Adam Feinstein has lowered his price targets for Community Health Systems and AmSurg, saying in both cases that lower patient volumes will keep the lid on any upside the companies will see in the coming quarters. In the case of CHS, Feinstein is counting on cost containment — they were up almost 7 percent in the first half, in line with revenue growth — but has taken a whopping 20 percent off his target for the stock (Ticker: CYH). For AmSurg, his target cut is less extreme, but that may be due to the fact that the surgery center chain (Ticker: AMSG) has been dealing with volume issues for more than a year. Sep 14, 2010 9:21 AM
|
Surgery center exec joins Illinois company
Bo Hjorth has left his vice president of operations post at Brentwood-based Community Care and joined an Illinois company that runs surgery centers in 10 states. At Regent Surgical Health, Hjorth — who's also worked at Symbion and The Rehab Group — will develop physician and hospital relationships from Middle Tennessee. Sep 8, 2010 2:19 PM
